跳至主要内容
临床试验/NCT02468596
NCT02468596终止不适用

Axonal Excitability Measured by QTRAC Technique in Patients With Anti-MAG Neuropathy

Fondation Ophtalmologique Adolphe de Rothschild15 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2014年11月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
6
试验地点
15
主要终点
QTRAC-measured refractority of the median nerve

研究概览

简要总结

The QTRAC method is an electrophysiological technique that assesses peripheral nerve axonal excitability, using computerized analysis of the muscular response of musculus abductor pollicis brevis, to series of electrical stimulations of the median nerve.

Because of its high sensitivity to small changes in axonal excitability, QTRAC may help improve the follow-up of patients suffering from peripheral neuropathy caused by anti-myelin-associated-glycoprotein antibodies (anti-MAG neuropathy), as axonal excitability is early affected in this disease.

The main aim of the study is to compare QTRAC results in anti-MAG neuropathy patients, with QTRAC results in healthy persons (matched for sex and age).

A secondary aim is to determine whether or not the disease's clinical severity (measured by quantitative clinical scores) is correlated with the results of the QTRAC and could be predicted by a model based on the several parameters measured in the QTRAC exploration.

100 anti-MAG neuropathy patients will undergo a QTRAC exploration and a thorough neurological examination with clinical scoring. The results will be compared with data (matched by sex and age) from the reference database on healthy subjects, that is provided with the QTRAC software.

The investigators expect to prove that QTRAC results are modified in anti-MAG neuropathy patients, and that the clinical severity of the disease can be predicted by a combination of QTRAC-measured parameters.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Anti-MAG neuropathy (peripheral neuropathy and IgM monoclonal gammopathy with anti-MAG activity superior to 1000 BTU)

排除标准

  • current treatment with a medication that modifies peripheral nerve excitability (e.g. anticonvulsivants)

结局指标

主要结局

QTRAC-measured refractority of the median nerve

时间窗: Inclusion

the duration of the refractory period of the median nerve (expressed in milliseconds) is automatically measured by the QTRAC system, using a series of double electrical stimulations (the first being supra-maximal and the second, sub-maximal) and progressively increasing the time between the two stimuli.

次要结局

未报告次要终点

研究者

申办方类型
Network
责任方
Sponsor

研究点 (15)

Loading locations...

相似试验